Skip to main content
Menu
Revvity logo
Contact us

Loading...

US
Search all

Loading...

Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

australia.webp Australia
austria.webp Austria
belgium.webp Belgium
brazil.webp Brazil *
canada.webp Canada
china.webp China *
denmark.webp Denmark
finland.webp Finland
france.webp France
germany.webp Germany
hong-kong.webp Hong Kong *
india.webp India *
ireland.webp Ireland
italy.webp Italy
japan.webp Japan *
luxembourg.webp Luxembourg
mexico.webp Mexico *
netherlands.webp Netherlands
norway.webp Norway
philippines.webp Philippines *
republic of korea.webp Republic of Korea *
singapore.webp Singapore *
spain.webp Spain
sweden.webp Sweden
switzerland.webp Switzerland
thailand.webp Thailand *
uk.webp United Kingdom
usa.webp United States
Login/Register here
Revvity web shop online account

Get exclusive pricing on all online purchases.

Login to your Revvity.com account for your account's pricing, easy re-ordering from favorites & order history, priority order processing, and dynamic order tracking.

Login Register
Revvity Omics portal accounts

Initiate a new order or access test status and results for clinical genomics or newborn screening services.

View login options
Breadcrumb
...
  • Home
  • Design and assembly of modular pin-point base editors for precise correction of pathogenic SNVs
base-editing1920x640
Scientific Poster

Design and assembly of modular pin-point base editors for precise correction of pathogenic SNVs

In this scientific poster, we present our pipeline for the design and development of bespoke modular Pin-point™ base editors with defined editing activities across therapeutic DNA target sequence space.

Read how we have established an arrayed screening platform and optimised gRNA libraries to characterise the editing activities of diverse combinations of Cas and deaminase modules at scale.

Knowledge obtained from the arrayed screens is used to guide the design of parallel screens to determine the efficiency and specificity of favourable base editor assemblies across pooled libraries covering all targetable pathogenic SNVs, with promising candidates validated and further optimised in cellular models harbouring SNV target sequences.

The Pin-point™ base editing platform technology is available for clinical or diagnostic study and commercialization under a commercial license from Revvity.

Download Resource

Design and assembly of modular pin-point base editors for precise correction of pathogenic SNVs

Download Scientific Poster
Revvity Logo

Loading...

    ©2025 Revvity - All rights reserved

    Revvity is a trademark of Revvity, Inc. All other trademarks are the property of their respective owners.